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ABSTRACT
As the science of quality improvement in health care
advances, the importance of sharing its accomplishments
through the published literature increases. Current
reporting of improvement work in health care varies
widely in both content and quality. It is against this
backdrop that a group of stakeholders from a variety of
disciplines has created the Standards for QUality
Improvement Reporting Excellence, which we refer to as
the SQUIRE publication guidelines or SQUIRE statement.
The SQUIRE statement consists of a checklist of 19 items
that authors need to consider when writing articles that
describe formal studies of quality improvement. Most of
the items in the checklist are common to all scientific
reporting, but virtually all of them have been modified to
reflect the unique nature of medical improvement work.
This ‘‘Explanation and Elaboration’’ document (E & E) is a
companion to the SQUIRE statement. For each item in the
SQUIRE guidelines the E & E document provides one or
two examples from the published improvement literature,
followed by an analysis of the ways in which the example
expresses the intent of the guideline item. As with the
E & E documents created to accompany other biomedical
publication guidelines, the purpose of the SQUIRE E & E
document is to assist authors along the path from
completion of a quality improvement project to its
publication. The SQUIRE statement itself, this E & E
document, and additional information about reporting
improvement work can be found at http://www.
squire-statement.org.
Reporting guidelines have played an increasingly
prominent part in the biomedical literature in the
past decade as researchers, editors, reviewers and
readers have made serious attempts to strengthen
the knowledge base of medicine. Guidelines have
been developed for reporting randomised con-
trolled trials (CONSORT),
12studies of diagnostic
accuracy (STARD),
3 epidemiological observational
studies (STROBE),
4 meta-analysis and systematic
reviews of randomised controlled trials
(QUOROM),
5 meta-analysis and systematic
review of observational studies (MOOSE),
6 and
for other designs and content areas. To date, it has
been challenging to publish reports of quality
improvement efforts, in part because improvement
work involves goals and methods that differ
fundamentally from projects that study disease
biology. The design, types of interventions,
data collection and analysis related to quality
improvement projects do not fit easily under
existing publication guidelines.
In 1999, the editors of Quality in Health Care
(since renamed Quality and Safety in Health Care)
published guidelines for quality improvement
reports (QIR).
7 These recommendations were
offered as ‘‘a means of disseminating good prac-
tice’’ so that practitioners may have the ‘‘opportu-
nity to learn from each other as the science of audit
and quality improvement matures’’ (p 76). Since
their publication, QIR have been used in over 50
published articles. While the QIR provide an
excellent structure for brief reports of improve-
ment work,
8 a more detailed and comprehensive
set of publication guidelines will be useful for larger
and more complex improvement studies.
Quality improvement (QI) is fundamentally a
process of change in human behaviour, and is
driven largely by experiential learning. As such, the
evolution and development of improvement inter-
ventions has much in common with changes in
social policy and programmes. At the same time,
the high stakes of clinical practice demand that we
provide the strongest possible evidence on exactly
how, and whether, improvement interventions
work. This double-barrelled epistemology makes
the study and reporting of work in QI extremely
challenging, particularly for the many ‘‘frontline’’
healthcare professionals who are implementing
improvement programmes outside the academic
and publishing communities. Finally, it is possible
that many journal editors, peer reviewers, funding
agencies and other stakeholders will not be familiar
with the methodologies for carrying out, studying
and reporting QI projects.
9
The lack of consensus-driven guidelines is
undoubtedly one factor contributing to the varia-
tion in reporting about improvement work and to
the variation in completeness and transparency of
that reporting. That variation has led to calls for
slowing the pace of improvement work, and for
increased diligence in applying traditional scientific
(that is, experimental) research methods in
improvement studies.
10 Others have taken just
the opposite position, and have called for pushing
forward with widespread, short-cycle improve-
ment work, in an effort to develop local learning
about what works, in what situations and for
whom.
11 In our view, this is not an ‘‘either/or’’
proposition; rather, both traditional research and
improvement work share a passion for developing
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systems. Research and clinical care delivery will both benefit
from more consistent, clear and accurate reporting of improve-
ment work.
Improvement efforts focus primarily on making care better at
unique local sites, rather than on generating new, generalisable
scientific knowledge. In that respect, most improvement work
(like most politics) is local. Despite its local focus, local
improvement frequently generate important new generalisable
knowledge about systems of care and about how best to change
those systems. Whether improvement interventions are small or
large, simple or complex, the Standards for QUality
Improvement Reporting Excellence (SQUIRE) guidelines pro-
vide an explicit framework for sharing the knowledge acquired
by examining those interventions closely, carefully, and in
detail.
DEVELOPMENT OF THE SQUIRE GUIDELINES AND THIS E & E
DOCUMENT
The SQUIRE guidelines were refined through a systematic
vetting process with input from an expert panel and through
public feedback. Specific details are provided elsewhere.
12 In
brief, this process involved the initial publication of guidelines in
September 2005
9; a period of open, public feedback; a consensus
conference in April 2007; and an asynchronous, email feedback
loop leading to this current publication. The SQUIRE guidelines
‘‘are intended primarily to support publication of the strongest
and most definitive evidence on quality improvement in the
permanent peer reviewed journal literature’’
9 (p 321). In this
E & E document, we use the current SQUIRE guideline checklist
(table 1) and identify exemplary examples from existing
literature to show how each guideline item can be addressed.
This E & E document is designed to aid authors as they embark
on an effort to share their work through publication using the
SQUIRE guidelines.
We formed an author group for the E & E document by
inviting as participants people whose published work concen-
trated on specific areas of improvement and assigned a SQUIRE
guideline item (table 1) to each author. The author identified
one or more articles that exemplified the components of that
item. He or she then wrote a commentary expanding on the
item’s content and linking the example article to the contents of
the guideline item. A few of the articles chosen as examples in
this paper were written using the initial SQUIRE guidelines,
9
but most were not. This E & E document demonstrates how it
is possible to clearly write about improvement work using the
SQUIRE guidelines. Also, many E & E sections include
descriptions of what could have been added to enhance the
example. Some may also link the contents of one section to
another (for example, Study questions (item 6) and Summary
(item 14)).
USING THE E & E DOCUMENT
The examples encompass a range of study designs. Some
examples relate improvement efforts at single institutions, some
are multicentre trials and one reports on simulation activities to
plan an intervention. In choosing these examples we made an
effort to reflect the great heterogeneity that currently char-
acterises the reporting of QI work. Use this E & E document as a
reference to assist with your writing. If you are a novice author
writing about improvement using the SQUIRE guidelines, we
recommend reading this entire article to become familiar with
all of the sections and the interactions and associations between
the sections. If you are a veteran writer of manuscripts, perhaps
you will scan this paper and delve deeper into some of the
aspects of SQUIRE that are unique from other manuscript
writing such as Intended improvement (item 5), the description
of the Setting (item 8), or the Outcomes regarding the evolution
of the intervention (item 13(a)). This E & E document is not
primarily intended to guide your choice of methods, design or
analysis for conducting improvement work, but rather as a
guide for writing about improvement; however, we recognise
that many of the elements included may be useful during the
planning and execution of an improvement project. Some of the
sections of this E & E contain more information about design
than others. It may be helpful to use the SQUIRE guidelines
themselves and this E & E to write an article ‘‘shell’’ as the
project is unfolding. This could ease the final preparation of the
manuscript for submission.
The SQUIRE guidelines are not exclusive of other guidelines.
For example, an improvement project or effectiveness study
that used a randomised controlled trial design should seriously
consider using both the CONSORT
12and the SQUIRE guide-
lines. Likewise, an improvement project that uses extensive
observational or qualitative techniques should consider the
STROBE
4 guidelines along with the SQUIRE guidelines. We
strongly believe that the SQUIRE guidelines are synergistic with
other publication guidelines, and together these will produce a
more complete manuscript than either set of guidelines alone.
We recognise that although the SQUIRE checklist contains 19
distinct sections, authors (or journal editors) may wish to
combine information from two or more sections depending on
the flow of information or the specific journal requirements. We
recommend using these guidelines to describe the project
clearly, not to strictly adhere to each guideline item. We
caution against using the guidelines too rigidly. A test of the
strict application of the Standards of Reporting Trials (SORT)
guidelines to a manuscript in 1995 produced a paper that was
less readable, illogically organised and lengthy.
13 14 Because
many of the guideline items contain a large amount of
information, strictly adhering to them would produce a
manuscript that is probably far too long for many journal
requirement (that is, usually about 3000 words). Some items
can be summarised as a table (item 13(a), Outcomes), figure
(item 12 Analysis and item 13(b), Outcomes), list or flow
diagram (item 4, Local problem or item 8, Setting). We
encourage authors to be cognizant of combining sections in
order to keep manuscripts concise and clear. Although we
believe that each of these items should be addressed, each item
need not be a separate heading or subheading. These guidelines
are best used as a way of checking the completeness, accuracy
and transparency of drafts.
ITEMS IN THE CHECKLIST
In this section, we provide a published example of each of the 19
SQUIRE checklist items (table 1). Examples are excerpts from
articles printed in peer-reviewed journals. Each example is then
followed by an explanation of the passage which comments on
the content of the example. Some explanations provide
additional guidance that may have strengthened the example
in light of the SQUIRE recommendations.
1 Title
a. Indicates the article concerns the improvement of quality
(broadly defined to include the safety, effectiveness,
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checklist
Text section; item number and name Section or item description
Title and abstract Did you provide clear and accurate information for finding, indexing, and scanning your paper?
1 Title (a) Indicates the article concerns the improvement of quality (broadly defined to include the safety, effectiveness, patient-centredness,
timeliness, efficiency and equity of care)
(b) States the specific aim of the intervention
(c) Specifies the study method used (for example, ‘‘A qualitative study,’’ or ‘‘A randomised cluster trial’’)
2 Abstract Summarises precisely all key information from various sections of the text using the abstract format of the intended publication
Introduction Why did you start?
3 Background knowledge Provides a brief, non-selective summary of current knowledge of the care problem being addressed, and characteristics of organisations in
which it occurs
4 Local problem Describes the nature and severity of the specific local problem or system dysfunction that was addressed
5 Intended improvement (a) Describes the specific aim (changes/improvements in care processes and patient outcomes) of the proposed intervention
(b) Specifies who (champions, supporters) and what (events, observations) triggered the decision to make changes, and why now (timing)
6 Study question States precisely the primary improvement-related question and any secondary questions that the study of the intervention was designed to
answer
Methods What did you do?
7 Ethical issues Describes ethical aspects of implementing and studying the improvement, such as privacy concerns, protection of participants’ physical
wellbeing and potential author conflicts of interest, and how ethical concerns were addressed
8 Setting Specifies how elements of the local care environment considered most likely to influence change/improvement in the involved site or sites
were identified and characterised
9 Planning the intervention (a) Describes the intervention and its component parts in sufficient detail that others could reproduce it
(b) Indicates main factors that contributed to choice of the specific intervention (for example, analysis of causes of dysfunction; matching
relevant improvement experience of others with the local situation)
(c) Outlines initial plans for how the intervention was to be implemented—for example, what was to be done (initial steps; functions to be
accomplished by those steps; how tests of change would be used to modify intervention) and by whom (intended roles, qualifications,
and training of staff)
10 Planning the study of the
intervention
(a) Outlines plans for assessing how well the intervention was implemented (dose or intensity of exposure)
(b) Describes mechanisms by which intervention components were expected to cause changes, and plans for testing whether those
mechanisms were effective
(c) Identifies the study design (for example, observational, quasi-experimental, experimental) chosen for measuring impact of the
intervention on primary and secondary outcomes, if applicable
(d) Explains plans for implementing essential aspects of the chosen study design, as described in publication guidelines for specific designs,
if applicable (see, for example, www.equator-network.org)
(e) Describes aspects of the study design that specifically concerned internal validity (integrity of the data) and external validity
(generalisability)
11 Methods of evaluation (a) Describes instruments and procedures (qualitative, quantitative or mixed) used to assess (a) the effectiveness of implementation, (b) the
contributions of intervention components and context factors to effectiveness of the intervention and (c) primary and secondary outcomes
(b) Reports efforts to validate and test reliability of assessment instruments
(c) Explains methods used to assure data quality and adequacy (for example, blinding; repeating measurements and data extraction; training
in data collection; collection of sufficient baseline measurements)
12 Analysis (a) Provides details of qualitative and quantitative (statistical) methods used to draw inferences from the data
(b) Aligns unit of analysis with level at which the intervention was implemented, if applicable
(c) Specifies degree of variability expected in implementation, change expected in primary outcome (effect size) and ability of study design
(including size) to detect such effects
(d) Describes analytical methods used to demonstrate effects of time as a variable (for example, statistical process control)
Results What did you find?
13 Outcomes (a) Nature of setting and improvement intervention
(i) Characterises relevant elements of setting or settings (for example, geography, physical resources, organisational culture, history of
change efforts) and structures and patterns of care (for example, staffing, leadership) that provided context for the intervention
(ii) Explains the actual course of the intervention (for example, sequence of steps, events or phases; type and number of participants at key
points), preferably using a time-line diagram or flow chart
(iii) Documents degree of success in implementing intervention components
(iv) Describes how and why the initial plan evolved, and the most important lessons learned from that evolution, particularly the effects of
internal feedback from tests of change (reflexiveness)
(b) Changes in processes of care and patient outcomes associated with the intervention
(i) Presents data on changes observed in the care delivery process
(ii) Presents data on changes observed in measures of patient outcome (for example, morbidity, mortality, function, patient/staff
satisfaction, service utilisation, cost, care disparities)
(iii) Considers benefits, harms, unexpected results, problems, failures
(iv) Presents evidence regarding the strength of association between observed changes/improvements and intervention components/
context factors
(v) Includes summary of missing data for intervention and outcomes
Continued
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care)
b. States the specific aim of the intervention
c. Specifies the study method used (for example, ‘‘A qualita-
tive study,’’ or ‘‘A randomised cluster trial’’).
Examples
(a) Outcomes of a quality improvement project integrating
mental health into primary care
15
(b) Improving newborn preventive services at the birth
hospitalisation: a collaborative, hospital-based quality improve-
ment project.
16
Explanation
The title of a quality improvement or patient safety paper
should indicate that its primary focus is quality improvement or
patient safety. The literature on quality improvement and
patient safety also includes papers that are primarily theoretical
and some that are large-scale studies about improving quality,
so it is helpful for the title to indicate that the paper is a report
of a specific intervention. The titles cited above refer to a
‘‘quality improvement project’’ indicating that it is report of a
specific intervention. Including the words ‘‘quality’’, ‘‘quality
improvement’’ or ‘‘patient safety’’ is important for readers to
identify the content and for the National Library of Medicine’s
Medline database to apply the correct keyword classification in
the medical subject headings (MeSH) for the article. Current
MeSH headings include healthcare quality, access and evalua-
tion; quality assurance, health care; quality control; quality
indicators, health care; quality of health care; and total quality
management.
The title may also describe the aim of the intervention and, if
possible, give some indication of the type of setting and
approach. Each of the above examples does this very well. While
the title cannot convey all the information about the article, it
will provide the first exposure of the material to the readers. A
concise and complete title entices readers to continue reading
into the body of the article.
2 Abstract
c Summarises precisely all key information from various
sections of the text using the abstract format of the
intended publication.
Examples
(a) Background: Inadequate blood pressure control is a
persistent gap in quality care.
Objective: To evaluate provider and patient interventions to
improve blood pressure control.
Design: Cluster randomized, controlled trial.
Setting: 2 hospital-based and 8 community-based clinics in
the Veterans Affairs Tennessee Valley Healthcare System.
Patients: 1341 veterans with essential hypertension cared for
by 182 providers. Eligible patients had 2 or more blood pressure
measurements greater than 140/90 mm Hg in a 6-month period
and were taking a single antihypertensive agent.
Intervention: Providers who cared for eligible patients were
randomly assigned to receive an e-mail with a Web-based link to
the Seventh Report of the Joint National Committee on the
Prevention, Detection, Evaluation and Treatment of High Blood
Pressure (JNC 7) guidelines (provider education); provider
education and a patient-specific hypertension computerized
alert (provider education and alert); or provider education,
hypertension alert, and patient education, in which patients
were sent a letter advocating drug adherence, lifestyle modifica-
tion, and conversations with providers (patient education).
Measurements: Proportion of patients with a systolic blood
pressure less than 140 mm Hg at 6 months; intensification of
antihypertensive medication.
Results: Mean baseline blood pressure was 157/83 mm Hg
with no differences between groups (P _ 0.105). Six-month
follow-up data were available for 975 patients (73%). Patients of
Table 1 Continued
Text section; item number and name Section or item description
Discussion What do the findings mean?
14 Summary (a) Summarises the most important successes and difficulties in implementing intervention components, and main changes observed in care
delivery and clinical outcomes
(b) Highlights the study’s particular strengths
15 Relation to other evidence Compares and contrasts study results with relevant findings of others, drawing on broad review of the literature; use of a summary table
may be helpful in building on existing evidence
16 Limitations (a) Considers possible sources of confounding, bias or imprecision in design, measurement, and analysis that might have affected study
outcomes (internal validity)
(b) Explores factors that could affect generalisability (external validity)—for example, representativeness of participants; effectiveness of
implementation; dose-response effects; features of local care setting
(c) Addresses likelihood that observed gains may weaken over time, and describes plans, if any, for monitoring and maintaining
improvement; explicitly states if such planning was not done
(d) Reviews efforts made to minimise and adjust for study limitations
(e) Assesses the effect of study limitations on interpretation and application of results
17 Interpretation (a) Explores possible reasons for differences between observed and expected outcomes
(b) Draws inferences consistent with the strength of the data about causal mechanisms and size of observed changes, paying particular
attention to components of the intervention and context factors that helped determine the intervention’s effectiveness (or lack thereof)
and types of settings in which this intervention is most likely to be effective
(c) Suggests steps that might be modified to improve future performance
(d) Reviews issues of opportunity cost and actual financial cost of the intervention
18 Conclusions (a) Considers overall practical usefulness of the intervention
(b) Suggests implications of this report for further studies of improvement interventions
Other information Were there other factors relevant to the conduct and interpretation of the study?
19 Funding Describes funding sources, if any, and role of funding organisation in design, implementation, interpretation and publication of study
Supplement
i16 Qual Saf Health Care 2008;17(Suppl I):i13–i32. doi:10.1136/qshc.2008.029058providers who were randomly assigned to the patient education
group had better blood pressure control (138/75 mm Hg) than
those in the provider education and alert or provider education
alone groups (146/76 mm Hg and 145/78 mm Hg, respectively).
More patients in the patient education group had a systolic
blood pressure of 140 mm Hg or less compared with those in the
provider education or provider education and alert groups
(adjusted relative risk for the patient education group compared
with the provider education alone group, 1.31 [95% CI, 1.06 to
1.62]; P _ 0.012).
Limitations: Follow-up blood pressure measurements were
missing for 27% of study patients. The study could not detect a
mechanism by which patient education improved blood
pressure control.
Conclusions: A multifactorial intervention including patient
education improved blood pressure control compared with
provider education alone.’’
17
(b) ‘‘Background: Performing a lumbar puncture in an unwell
child can cause anxiety in both the parent and the junior doctor.
There is increasing evidence of post-lumbar-puncture complica-
tions in this age group.
Aims: To improve the documentation, consent for and
technical performance of paediatric lumbar punctures to 100%
of the required standard within 3 months.
Setting: The paediatric emergency department of a the Royal
North Shore Hospital (University of Sydney, Sydney,
Australia).
Participants: Paediatric emergency staff, including residents,
registrars and consultants.
Methods: Medical records of 40 consecutive children who had
undergone a lumbar puncture in the 6 months before the
introduction of the lumbar-puncture proforma were reviewed.
After introduction of the proforma, the records of 25
consecutive patients were reviewed to assess changes in the
outcome measures. Before introduction of the proforma, junior
medical staff were instructed in the procedure using specialised
lumbar puncture manikins (Baby Stap; Laerdel, USA).
Results: Before introduction of the proforma, the median
number of documented indicators was 4, out of a maximum of
12. There was almost no documentation of parental consent,
patient complications and analgesia. Introduction of the
proforma resulted in a highly marked increase to a median of
12 documented indicators per patient (p,0.01, 95% confidence
interval 6 to 8).
Conclusions: The introduction of a lumbar-puncture pro-
forma and formal teaching sessions using a paediatric manikin
led to a marked improvement in the documentation of
paediatric lumbar-punctures. Lumbar-punctures can be per-
formed only by accredited medical officers who have achieved
competency on the lumbar-puncture teaching manikin.’’
18
Explanation
The purpose of an abstract is to summarise the essentials of the
work that was done, so readers can decide whether it is relevant
to their practice or research. Abstracts are the only information
included in electronic search databases such as Medline.
Moreover, many readers never venture beyond the abstract; in
fact, readers often start reading the abstract by reading the
‘‘bottom line’’—that is, the conclusions section, and read the
rest only if that catches their interest. For these reasons, the
abstract—particularly the conclusions section—must be clear,
succinct and accurate. To assist readers in locating articles that
are of interest to them, abstracts should contain keywords that
allow librarians to accurately classify the work into searchable
categories.
Different journals have different requirements, so the above
examples illustrate how the critical elements can be effectively
incorporated into the abstract. Despite format differences, both
abstracts clearly indicate that the paper reports the results of a
quality improvement project.
17 18 The aim and/or primary
objective of the project is clearly stated as well as the existing
quality gap. A brief description of the setting and participants is
also provided. The methods section describes the initial strategy
for improvement while the results describe the impact of the
changes. The evolution of the intervention may be difficult to
convey in the limited space of an abstract, but should at least be
mentioned if possible. The conclusion summarises the project
and describes the ‘‘generalisable’’ lessons learned. Both of these
abstracts are clearly written, so the reader is able to evaluate the
contents of the entire manuscript quickly and intelligently.
3 Background knowledge
c Provides a brief, non-selective summary of current knowl-
edge of the care problem being addressed, and characteristics
of organisations in which it occurs.
Example
‘‘Several studies document that patients frequently show signs
and symptoms of clinical instability before actual cardiac arrest.
Schein et al found that 70% of patients showed evidence of
respiratory deterioration within 8 hours of cardiac arrest. Other
warning signs include hypotension, hypertension, tachycardia,
tachypnea, and altered mental status. Despite documentation of
the patient’s clinical deterioration and physician notification,
interventions are frequently inappropriate or absent. The rapid
response team concept has evolved as a means of extending
critical care outside of the intensive care unit to intervene early
and to prevent deterioration to cardiac arrest. We recently
implemented a rapid response team at our hospital and this study
evaluates our early experience with this approach… .’’
‘‘Saint Anthony Central Hospital is a busy community-based
urban Level I trauma center in Denver, CO. There are over 2,500
trauma admissions annually and just over 600 of the admissions
have an Injury Severity Score .16. Moreover, St. Anthony
Central Hospital functions as a tertiary referral center for
multiple other facilities within the Centura health hospital
Network. Experienced, board certified trauma surgeons are
available inhouse 24 hours a day, 7 days a week (24/7). Similarly,
critical care physicians are also inhouse and available at all
times.’’
‘‘Before March, 2005, patient clinical deterioration was managed
by the inhouse physicians, both trauma and critical care, after
notification by the nurse caring for the patient. During the year
before March 2005, we developed a rapid response team to react
to patient clinical deterioration outside of the intensive care unit;
in effect, bringing critical care to the patient’s bedside.’’
19
Explanation
To understand a quality improvement intervention clearly,
readers need to understand how the intervention relates to
general knowledge of the care problem. This requires the
authors to place their work within the context of issues that are
known to impact the quality of care. Context means ‘‘to weave
together’’.
20 The interweaving of the issues that stimulated the
improvement idea and a variety of spatial, social, temporal and
cultural factors within the local setting form the canvas upon
which improvement is painted. The explanation of context
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description of the organisation (types of patients served, staff
providing care and care processes before introducing the
intervention) will help readers to determine if findings from
the study are likely to be transferable to their own care setting.
In studies with multiple sites, a table can be a convenient way
to summarise differences in context across sites. The table can
specify the structures, processes, people and patterns of care
that are unique to each site and assist the reader in interpreting
results.
The above example places the improvement work within the
context of a recognised need to provide earlier intervention to
patients who are experiencing clinical deterioration; however,
the authors also provide substantial details about their facility
as a Level I trauma centre that is highly invested in critical care
delivery. This description will capture the attention of readers
from similar facilities, as the results may have implications for
their own institutions. Conversely, this also allows readers
whose context is very different to interpret the results
appropriately.
Whereas controlled trials attempt to control the context to
avoid selection bias, quality improvement studies often seek to
describe and understand the context in which the delivery of
care occurs. Pawson et al propose using form of inquiry known
as ‘‘realist evaluation’’ to explore complex, multi-component
programmes that are designed to change performance. The
relevant questions in realist evaluation are: ‘‘WHAT is it about
this kind of intervention that works, for WHOM, in what
CIRCUMSTANCES, in what RESPECTS and WHY?’’
21
Answering these questions within a quality improvement
report requires a thoughtful and thorough description of the
background circumstances into which the change was intro-
duced.
The description of the background knowledge and local
context of care will be blended between checklist item 3
(Background knowledge) and item 4 (Local problem). Placing
information into the exact category is less important than
ensuring the background knowledge, local context and local
problem are fully described.
4 Local problem
c Describes the nature and severity of the specific local
problem or system dysfunction that was addressed.
Example
‘‘A completion rate of 90% [for screening colonoscopy] is
considered acceptable and since the start of our programme has
been accepted by the UK endoscopy community. Median
colonoscopy completion rates found in an audit in three regions
in the United Kingdom were between 57% and 73%, depending
on how completion is defined, although some institutions report
adjusted completion rates of more than 90%. In the United
States, crude completion rates of 95% have been reported in large
series (such as one series of 3465 colonoscopies), suggesting that a
90% completion rate is achievable in routine practice. The impact
of incomplete colonoscopies on the success of a proposed
national colorectal screening programme has been highlighted.
We were aware that our colonoscopy completion rate was low,
and we wished to attain the suggested standard so that our
patients would benefit by avoiding subsequent barium enema or
missed lesions.’’
22
Explanation
The introduction to a quality improvement paper should
explicitly describe the existing quality gap. To be as specific as
possible, authors should describe the known standard or
achievable best practice, and then provide evidence that the
local practice is not meeting that standard. These authors
specified that 90% colonoscopy completion rates are achievable,
yet local completion rates only range from 57% to 73%.
Comparing and contrasting local, regional and national
outcomes helps to frame this study against other outcomes.
By comparing colonoscopy completion rates in the UK with
published completion rates in the United States, the authors
provide documentation that better performance is both
quantifiable and achievable. In the absence of a known
achievable standard of care, authors need to state their rationale
for the level of performance they set as their goal.
Although the implications of the quality gap need not be
described in detail, a brief summary of the individual patient,
local system and (if applicable) national implications help to
frame the study’s importance. In the above example, the
authors point to documentation that suboptimal colonoscopy
completion rates can hinder a national healthcare initiative by
allowing missed diagnoses, thus increasing morbidity and
mortality, cost and medicolegal risk. Further implications of
the quality gap can be addressed in the discussion section (see
guideline items 15, Relation to other evidence and item 18,
Conclusions).
5 Intended improvement
a. Describes the specific aim (changes/improvements in care
processes and patient outcomes) of the proposed interven-
tion
b. Specifies who (champions, supporters) and what (events,
observations) triggered the decision to make changes, and
why now (timing).
Example
‘‘For many years our busy MICU [medical intensive care unit]
struggled with CR-BSIs [catheter-related bloodstream infec-
tions]. In 2002 the CR-BSI rate was 44% higher than the national
median of 5.2 per 1000 catheter-days. Like many hospitals, we
had historically focused on infection surveillance and staff
education. However, we recognised that more innovative
strategies were needed to tackle this ongoing complex problem.
The impressive utility of CQI [continuous quality improvement]
in other healthcare settings, coupled with successful reports from
other high risk industries, encouraged us to consider a CQI
approach… .’’
‘‘Our primary goal was to show that real time measurement of
CVC [central venous catheter] care was feasible in the MICU.
We anticipated these new process measurements would guide
CQI efforts and thereby lead to a reduced CR-BSI rate. To
increase staff appreciation of the link between process measures
and clinical outcomes, we fed bundled data back to providers.’’
‘‘We assembled a voluntary interdisciplinary team with at least
one MICU leader, infectious disease expert, front line staff
member, and quality improvement expert. The team’s goal was
to develop a system for measuring the process of CVC care in real
time with the understanding that this information would guide
future improvement activities aimed at reducing infections. The
team compiled a list of risk factors by reviewing the published
literature on CR-BSIs, and then classified these risk factors
depending on whether they occurred during the insertion or daily
maintenance. When deciding where to focus their initial efforts,
the team selected CVC insertion as the starting point. Several
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inserted by trainees and there was a high likelihood of practice
variability; (2) there was strong evidence linking certain insertion
behaviors with CR-BSIs; and (3) CVC insertion was easily
defined and amenable to improvement.’’
23
Explanation
A quality improvement paper should describe the events or
information that lead to the need for making a change. Authors
should include specific data or other organisational factors that
are relevant to the intended improvement. The idea for
improving care rarely occurs isolated from other events. These
authors acknowledge that infection surveillance and staff
education efforts had been in place in the specified institution
but were insufficient to reduce the rate of catheter-related
infections. By describing existing and previous work to improve
care, authors place the current effort in relation to former
initiatives.
The aim of the improvement effort should be clearly
described. As in this example, the statement contains informa-
tion about the specific goal to be achieved and how this will be
measured. The example above indicates that the project is the
first part of a feasibility study to understand whether real-time
measurement of catheter-related infections is possible. A second
goal of the intended improvement is to assess whether the use
of real-time measures will lead to reduction in the rate of
infection.
In addition, authors should describe which aspect(s) of care
was the focus of the intended improvement. The authors above
choose to focus on the insertion of the central venous catheter,
and they clearly describe the rationale for this choice both in
terms of evidence from the existing literature and from local
factors related to their intensive care environment.
Finally, a description of the intended improvement should
include the people who were involved in the effort. These
authors note four different members of the team and highlight
their different roles. Including the roles of individuals who
participate in an improvement effort provides the reader with
information related to what expertise was brought to the group.
Improvement efforts are often initiated by leaders in a unit,
clinic, hospital or health care organisation. If such institutional
support or expectations exist for an intended improvement,
stating these factors can assist the reader in understanding what
other organisational factors may have facilitated the improve-
ment effort.
6 Study question
c States precisely the primary improvement-related question
a n da n ys e c o n d a r yq u e s t i o n st h a tt h es t u d yo ft h e
intervention was designed to answer.
Example
‘‘In this article, we describe a generally applicable computer
simulation model to analyze access times for hospital services
and to investigate the capacity needed to reduce these access
times. We give both the analytical model and the simulation
model, including the results following implementation in two
outpatient departments of the AMC [Academic Medical Center].
The questions that guided our study were:
– To what extent are analytical models appropriate and
when is simulation essential for more insight?
– Is it possible to generalize the models and results to other
departments?’’
24
Explanation
The study questions are a fundamental component of the
introduction because they clarify the study of the intervention
and note the relation that these questions have to the aim of
the study. The study questions are in contrast to the
improvement aim that would be stated in item 5, Intended
improvement. The aim specifies the intended clinical (or
system) change while the study questions focus on the
mechanism(s) by which the intervention works and how
effective the intervention is, or can be. In the example, the
authors make this distinction by outlining the goal of the
intervention, the performance gaps that motivated it, then
outlining the study questions in terms of how and why the
authors evaluated the intervention. The detail provided by the
study questions also lend insight into the context issues that
impact the study (for whom it works, under what circum-
stances and why), so the study questions should flow naturally
from the description of the context.
Study questions provide a synopsis of the investigator’s
thinking about the local quality gap. The questions provide an
important link between the perceived causes of that gap and
the methodology selected to close the gap. In the above
example, the investigators hypothesised that a mismatch
between supply and demand was causing lengthy waits for
new patients. Their clearly defined study questions served to
focus the improvement intervention which is described in detail
in their methods section. Study questions can help introduce
the data that were used, which may include a blend of process
and outcome measures from both quantitative and qualitative
methods. Additionally, these study questions address the
generalisability of the intervention, which in this case refers
to the applicability of their models to other clinics. These
generalisable concepts are addressed further in the discussion
section (see guideline items 16(b) Limitations and 17(b)
Interpretation).
7 Ethical issues
c Describes ethical aspects of implementing and studying the
improvement, such as privacy concerns, protection of
participants’ physical wellbeing, potential author conflicts
of interest and how ethical concerns were addressed.
Example
(a) ‘‘Residents [of the nursing home] who were not expected to
live more than 30 days from the date of enrollment (as judged by
their attending physician and nurse),those residents with a
history of anaphylactic or serious allergic reaction to fluoroqui-
nolones, or those residents with advance directives precluding
transfer to hospital were excluded. The research protocol was
approved by St Joseph’s Healthcare Hamilton Research Ethics
Review Board. All participants or their designated surrogate
decision makers gave informed consent.’’
25
‘‘Study nurses made routine visits to the nursing home to assess
resident eligibility, discuss the trial obtain informed consent, and
enrolled residents.’’
25
(b) ‘‘[T]he purpose of our improvement project was to improve
the consistency and reliability of the caesarean delivery process
and to achieve emergency caesarean delivery response times of
less than 30 minutes.’’
26
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A quality improvement publication should reflect and affirm
that ethical standards have been addressed in the planning and
implementation of the study. As efforts to enhance the quality
of health care grow, there is a need to ensure that ethical
practices are reflected in these efforts. The ethical principles of
autonomy (do not deprive freedom), beneficence (act to benefit
the patient, avoiding self-interest), non-maleficence (do not
harm), justice (fairness and equitable care) and do your duty
(adhering to one’s professional and organisational responsibil-
ities) form a foundation for the delivery of health care. Those
same principles should underpin the planning, implementation,
and publishing of quality improvements activities.
Some of the specifically noted ethical standards for quality
improvement activities are derived from the above principles
and include the following: social or scientific value from the QI
activity (responsible application of limited resources); scientifi-
cally valid methodology (avoiding inappropriate harm to
subjects and waste of resources); fair participant selection to
achieve an equitable distribution of burdens and benefits
(justice); favourable risk-benefit, limiting risks and maximising
benefits (non-maleficence, avoiding harm); respect for partici-
pants by respecting privacy and confidentially (respect for
individual autonomy); informed consent when minimal-risk
quality improvement activities is part of patient’s treatment
(respect for autonomy); and independent review of the ethical
conduct and accountability of the quality improvement
(professional, organisational and public accountability).
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Another ethical standard related to professional responsibility
and organisational accountability is avoiding any real or
perceived conflicts of interest. These ethical standards form
the foundation for ensuring the ethical quality of QI.
Example (a) above is from a formal, planned QI research
study designed to produce generalisable results. The reader has a
clear understanding that the study addressed ethical standards
because the protection of the participants was noted in both the
research design and consent process. The other ethics guidelines
were addressed as part of the independent review process.
Because this example meets the generally accepted interpreta-
tion of a research project as reflected in the Common Rule as a
‘‘systematic investigation, including research development,
testing, and evaluation, designed to develop or contribute to
generalisable knowledge,’’
28 the quality improvement activity
must adhere to these requirements. The article indicates that
the QI protocol was reviewed and approved by the St Joseph’s
Healthcare Hamilton Research Ethics Review Board. This
statement verifies that the protocol received independent
review, suggesting that its protocol was appropriately designed
to address a scientifically and socially important question, used
a fair participant selection process, obtained adequate informed
consent process and involved a suitable risk-benefit ratio.
The authors in example (a) provided further detail on the
ethical conduct of the project by stating that study nurses
discussed the trial and sought informed consent to enrol eligible
patients who met the inclusion criteria. Those nursing home
‘‘residents who were not expected to live more than 30 days
…or those residents with advance directives precluding transfer
to hospital were excluded’’ from the study.
25 The reported
findings indicate that some nursing homes chose not to
participate in the study. The authors also report that ‘‘consent
could not be obtained from next of kin’’ from a total of 89
nursing residents or their surrogate and five refused to consent
to the study.
25 The refusal to participate in the research study by
some patients or their surrogates suggests the scope of the
shared decision process—fostering an ethically grounded valid
consent and refusal process.
In QI, ethical standards must also be addressed in the
planning and implementation of the activity because improve-
ment activities carry the potential for risk to patients or misuse
of organisational resources. In order to foster adherence to
ethical guidelines, healthcare organisations should ensure that
‘‘ethical oversight of QI…becomes part of an enhanced
accountability system for professional responsibility and the
supervision and management of clinical care’’ (p 688).
27 An
example of non-research quality improvement providing ‘‘sys-
tematic, data-guided activities designed to bring about immedi-
ate improvements in the healthcare delivery in particular
setting’’
27 is found in example (b).
26 The article describes a
carefully planned and implemented process to improve the
consistency and reliability of the caesarean delivery process in a
small rural hospital; however, the publication does not explicitly
indicate whether an independent review occurred, including the
ethical conduct of the effort. It would be reasonable to expect
that the QI project coordinators (authors) indicate that
previously noted
27 QI ethical guidelines were addressed in the
planning and implementation of the project. This is not meant
to suggest that an institutional review board (IRB) review is
necessary for such non-research QI activity; however, authors
should indicate that the QI activities they are reporting adhered
to appropriate ethical guidelines in their publications.
The ethical concerns regarding potential conflict of interest in
QI efforts were significantly different in the two publications.
In example (a) which is a QI research publication,
25 the authors
provide detailed disclosure information regarding the authors’
contribution to the publication, financial disclosures, funding
support, role of sponsors and acknowledgments. The extensive
disclosure at the end of article is likely to be the journal’s
requirement, and it provides the necessary transparency
regarding any potential conflict of interest to be considered by
the reader. Example (b)
26 provides only a brief acknowledgement
that does not fully address the real, potential or lack of conflict
of interest. Because QI activities often seek to improve delivery
practices, outcomes, effectiveness and efficiency of healthcare
services at a particular facility, QI investigators may encounter
potential conflicts between obligations to individual patients
and the general care provided by the facility or organisation.
Therefore, QI publications should include disclosure of conflict
of interest information.
The central issue in these examples is not whether the
publication is a research project or not, rather that the reader is
assured that ethical standards have been addressed in the
planning and implementation of the QI activity. Transparency
regarding the adherence to ethical standards is a vital aspect of
the preparation of the manuscript and the journal’s decision to
publish—reinforcing the point that ethics is an essential
element of quality and of quality improvement activities.
29
8 Setting
c Specifies how elements of the environment considered most
likely to influence change/improvement in the involved site
or sites were identified and characterised.
Example
‘‘Alice Peck Day Memorial Hospital (APD) is a 32 bed hospital
located in Lebanon, New Hampshire, USA. The birthing center
has six labour/delivery/recovery/postpartum rooms and a Level I
nursery. This unit is usually staffed by a minimum of two nurses.
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project started in 2001, two independent physician groups,
employing four providers, admitted obstetric patients. Paediatric
services were provided by 16 physicians distributed among four
independent practices. Three anaesthesia practitioners provided
continuous coverage. Caesarean deliveries are performed in the
hospital’s main operating room. The operative team consisted of
the attending obstetrician, the first assistant, the paediatric
provider, the anaesthesiologist, two operating room staff and the
birthing centre nurse.
As the hospital has grown, physician groups have expanded,
consolidated and changed practice patterns. Currently three
obstetricians and three CNMs [clinical nurse midwives] are
employed by the hospital. One additional CNM has a small
independent practice. The majority of in-house paediatric
services are now provided by one hospital-owned practice that
employs four family practitioners and two paediatricians.
Anaesthesia and operating room services are unchanged;
although, we no longer consistently have a first assistant at all
caesarean deliveries.’’
26
Explanation
This section describes the specific and relevant elements of the
setting in which the improvement effort took place. It is an
opportunity to expand upon the basic description that may be
contained in the Background knowledge (item 3) and Local
problem (item 4) items. In the example, this hospital is located
in a rural part of New Hampshire, and ‘‘rural’’ is also included in
the title of this article (item 1). Rural sites often are hospitals
with smaller patient capacity (that is, number of hospital beds)
and with smaller professional staff. The authors further describe
the challenges of meeting emergency caesarean section time
targets with the limited resources at this site, thus illustrating
the financial and staffing limitations in this setting.
Improvement in this example was not a matter of hiring a
coordinator or purchasing new equipment; it was predicated on
the current staff using the currently available resources, so
describing the current situational factors—and how they
changed throughout the study period—is stated.
Implementing the changes described in this paper could be
much different in a highly staffed, urban hospital with different
staffing resources.
The paper later describes that the improvement efforts were
undertaken in response to a sentinel event that involved a
caesarean delivery response time, thus providing information
regarding the underlying culture in which the change took
place. In a small hospital, an adverse outcome affects almost
everyone on staff. Describing how this event galvanised support
for change was key in this article. This example could have been
strengthened by more specific information about the degree of
leadership support from middle and senior management as well
as information about the history of previous change efforts, if
any.
This framework of context and process description is
necessary for readers to understand the generalisability (exter-
nal validity) of the report. Identifying, understanding, and
making changes to the processes and structures of care are
essential to improvement work. This is in contrast to controlled
trials where context is held constant through the design (for
example, randomisation, blinding) and analysis (for example,
regression analysis). Clearly describing the context for the
reader will assist in their efforts to extrapolate to their own
setting.
9 Planning the intervention
a. Describes the intervention and its component parts in
sufficient detail that others could reproduce it
b. Indicates main factors that contributed to choice of the
specific intervention (for example, analysis of causes of
dysfunction; matching relevant improvement experience of
others with the local situation)
c. Outlines initial plans for how the intervention was to be
implemented—for example, what was to be done (initial
steps; functions to be accomplished by those steps; how
tests of change would be used to modify intervention), and
by whom (intended roles, qualifications and training of staff)
Example
‘‘Twenty-three primary care organizations voluntarily enrolled in
the Depression Breakthrough Series. This intervention was
coordinated by the Improving Chronic Illness Care team and the
Institute for Health Care Improvement and supported by the
Robert Wood Johnson Foundation. Six private-sector organiza-
tions each paid a fee of $12,500, and 11 public-sector organiza-
tions that were financed by the Health Resources and Services
Administration received a scholarship from the Robert Wood
Johnson Foundation to cover the fee. Each team (typically a
physician, a care manager, and a coordinator) attended three
learning sessions for training by institute faculty on ‘‘plan-do-
study-act’’ cycles and other techniques for rapid quality
improvement and by experts in implementing the chronic care
model. Between sessions, teams attempted to make changes and
participated in monthly cross-site conference calls with expert
faculty.
On the basis of the chronic care model, which envisions the
delivery of effective treatment for chronic illness by restructuring
care systems, teams were encouraged to design programs that
implement changes within each of six areas… .’’
30
Explanation
Readers can best understand the meaning and applicability of a
quality improvement intervention when the key features of the
planning process are well documented. Unlike tightly controlled
research studies, which tend to be studies of ‘‘conceptually neat
and procedurally unambiguous’’ interventions like drugs, tests
or procedures, studies of quality improvement interventions are
intended to help others predict whether a particular approach to
changing performance is likely to result in improved routine
care. Routine care cannot be dissociated from its contexts, so
readers need to understand how a quality improvement
intervention influenced and was influenced by the context
within which it was carried out. The planning of the
intervention is a key component of this.
In the example, contextual factors include intervention
financing and number and type of organisations. Additional
contextual factors, such as the size, academic affiliations, rural
or urban location, region of the country and characteristics of
the patient population are known to have major effects on
quality of care and intervention implementation.
Organisational characteristics of participating sites, particularly
those characteristics relating to elements of the chronic illness
care model, as well as those describing an organisation’s culture
or leadership, should also be included in this section.
The example contains very specific information about the
details of the initial intervention. It specifies the organisations,
teams, faculty members and theoretical background (PDSA,
model for improvement, chronic care model) used in setting up
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sessions and monthly telephone calls. Local improvement teams
modified and adapted their intervention plans at each step. All
of these facets of the initial planning process help the reader to
anticipate the conditions under which the quality improvement
intervention’s results would be most applicable.
In some cases, intervention planning focuses on policy
change, with little structuring of the specific change in the
local setting. In other cases, an organisation, community or
microsystem within an organisation may adopt a previously
designed set of changes as its intervention. If the focus is
adoption of pre-set changes, the planning phase may particu-
larly emphasise the development of evaluation goals, standards
and methods. In each case, the report of the planning phase
should identify the focus of the quality improvement interven-
tion and the design decisions related to that focus. For example,
if the QI intervention is being developed de novo (or if it
requires substantial adaptation from previous models), the
report of the planning phase write-up should focus on piloting
changes, such as through PDSA cycles. If the QI intervention is
a policy change alone, the planning phase write-up should focus
more on what was done to garner feedback from stakeholders or
to pilot early evaluation designs.
In many cases, such as in the example above, an organisation
or community intends either to substantially adapt a previous
intervention. Describing the financial and technical support for
the planning process and for the interventions is important,
since both the type and degree of support provided for both the
planning phase and the interventions can influence the scope of
changes that are undertaken. In addition, as is usually the case,
the specific sources of financial support may raise issues of
actual or potential conflicts of interest, even when the sources
are not for profit. Some of this information may be cross-
referenced with information in the sections about Ethical issues
(item 7) and/or Funding (item 19). Readers need to understand
each of these issues to predict how well the quality improve-
ment intervention may apply under other circumstances.
10 Planning the study of the intervention
a. Outlines plans for assessing how well the intervention was
implemented (dose or intensity of exposure)
b. Describes mechanisms (theories) by which intervention
components were expected to cause changes, and plans for
testing whether those mechanisms were effective
c. Identifies the study design (for example, observational,
quasi-experimental, experimental) chosen for measuring
impact of the intervention on primary and secondary
outcomes, if applicable
d. Explains plans for implementing essential aspects of the
chosen study design, as described in publication guidelines
forspecificdesigns(see,forexample,www.equator-network.
org)
e. Describes aspects of the study design that specifically
concerned internal validity (integrity of the data) and
external validity (generalisability).
Example
‘‘The specific aim of this project was to eliminate catheter-related
blood stream infections (CRBSI) throughout intensive care units
(ICUs) in Michigan. We used a multiple time series design. The
study population was all Michigan ICUs willing to participate.
The primary outcome (dependent) variable was the rate of
CRBSI…Hospitals were to adhere to the Centers for Disease
Control (CDC) definition of catheter-related bloodstream infec-
tion during the study period…The quarterly rate of infection was
calculated as the number of infections per 1000 catheter-days for
each 3-month period. Quarterly rates were assigned to one of
eight categories on the basis of when the study intervention was
implemented: at baseline, during the implementation period, or
during one of six 3-month intervals occurring up to 18 months
after implementation.
…To understand compliance with the interventions, teams
completed a monthly form, called the team check up tool that
evaluated what activities they did during the prior month, the
number of times they met with their team and senior leader, and
the barriers they were facing. All teams participated in bi weekly
conference calls to discuss the project.’’
31
Explanation
This study highlights the multiple trade-offs that occur in
designing and reporting a quality improvement study. This
report states the design as a multiple time series in which all
ICU sites willing to participate were included. While a cluster
randomised design may have been more robust, it was not
tenable because all the teams wanted the intervention and none
wanted to be randomised to the control—a common desire
when testing the implementation of known, effective interven-
tions. Although it is not necessary to note this, alternative
designs that were considered and deemed to be untenable
should be noted in the limitations. The effectiveness of the
intervention for eliminating catheter related blood-stream
infections (CRBSI) was clearly known from previous studies,
32
so this was an assessment of the effectiveness of the
implementation of the interventions across many sites. The
description of this should account for the size and scope of the
implementation. This example was a large-scale implementa-
tion across a large geographical area, so the description includes
mention of the study design (‘‘multiple time series’’), the
operational definition of the main outcome measure (‘‘the
Centers for Disease Control (CDC) definition of catheter-
related bloodstream infection’’) and how data integrity was
maintained (example not included). An improvement study at
one location may include a very different, but equally precise,
description of the plan of the study of the intervention.
There is often a struggle between collecting data that are
scientifically sound yet feasible. Quality improvement studies
often have limited resources and data collection may be
voluntary. As such, this study notes the reduced quantity—
but not quality—of data collected. The definition of CRBSI, the
main outcome measure, was clear (although not included in the
above example), but there were no data collected about
secondary outcome variables such as the type of organism or
adherence to the evidence-based recommendations. There was
no valid and feasible way to do this as independent observation
would have required placing an observer in the ICU for
substantial amounts of time; a costly endeavour for central
lines which are often placed at irregular intervals. The study also
reported on data quality control including data definitions,
training and amount of missing data. Nevertheless, because of
insufficient resources, it did not report more robust methods of
data quality control such as duplicate data entry or inter-rater
reliability.
This study demonstrates how the intervention was guided by
the study goal: eliminate CRBSI. When designing any study, the
team invariably faces trade-offs. This example demonstrates
how the aim, the design of the study and the measures were
identified and implemented across multiple sites in a large
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by the systems willing to make changes. There are many ways
to design a quality improvement study, and the study aims
guide that design and the analysis. When writing about the
study of the interventions, be sure to integrate the SQUIRE
publication guidelines with guidelines for reporting on the
specific study design whether it is a qualitative epidemiological
study (STROBE),
4 a randomised controlled trial (CONSORT)
12
or other design.
11 Methods of evaluation
a. Describes instruments and procedures (qualitative, quanti-
tative or mixed) used to assess (a) the effectiveness of
implementation, (b) the contributions of intervention
components and context factors to effectiveness of the
intervention and (c) primary and secondary outcomes
b. Reports efforts to validate and test reliability of assessment
instruments
c. Explains methods used to assure data quality and adequacy
(for example, blinding; repeating measurements and data
extraction; training in data collection; collection of suffi-
cient baseline measurements).
Example
‘‘All indicators were dichotomous variables thought to be
amenable to simple quality improvement measures. In general,
the quality indicators allow for a longer time frame to administer
the clinical intervention (vaccine, aspect of physical examination,
or laboratory test) than suggested by the ADA [American
Diabetes Association] guidelines. This leniency means that
performance for these indicators should be better than for the
ADA guidelines because decreasing the time frame for the clinical
intervention would probably decrease average indicator perfor-
mance.
We ascertained from the medical record whether the following
appropriate care was performed for each eligible patient at least
once during the 18-month period: (1) measurement of long-term
glucose control as reflected by at least 1 test of glycosylated
hemoglobin (hemoglobin A1c) or fructosamine, (2) measurement
of serum cholesterol, (3) measurement of serum triglycerides, (4)
measurement of serum creatinine, (5) performance of in-office
foot examination, and (6) administration of influenza vaccine.
Performance on an indicator was quantified by dividing the
number of eligible patients who received the item by the total
number of eligible patients.
…All data for the quality measures were obtained from chart
review according to methods previously described. Charts were
photocopied and abstracted centrally using MedQuest, publicly
available software developed for HCFA [Health Care Finance
Association] (http://www.hcfa.gov). The ACQIP [Ambulatory
Care Quality Improvement Program] investigators developed a
standardized chart review protocol and refined the protocol
through pilot testing. As part of the protocol, abstractors
underwent intense training with competency certification. The
MedQuest chart review module contained standard lists for
variable synonyms, medications, diagnoses, and procedures.
Throughout the chart abstraction period, 5% of charts were
randomly sampled for dual abstraction and physicians evaluated
chart abstractions for validity. Validity and reliability of all key
variables were at least 95%.’’
33
Explanation
The description of the methods of evaluation outlines what the
study used to quantify improvement, why the measures were
chosen and how the investigators obtained the data. The
measures chosen may be outcomes or process measures,
continuous or categorical, biological or behavioural. The
measures also must be sensitive enough to detect meaningful
change in the processes and outcomes. Measures should have an
accepted, clear operational definition so that changes in the
values can be determined statistically and, more importantly,
significant to the clinical problem being studied. Different
perspectives, such as provider, patient, payer or societal, should
also be considered during the delineation of measures.
In the example, the improvement project focused on
achievable benchmarks in diabetes care. The study’s measures
were the proportion of the population receiving certain tests or
interventions. These are process measures. If the study had
looked at the change in haemoglobin A1c values, the number of
influenza cases prevented or change in the quality of life of the
patients, then the measures would have been outcome
measures.
Whether process or outcome, measures should reflect a
reasonable range of potential changes that may result from
the intervention. Haemoglobin A1c is frequently used as an
outcome measure to determine adequacy of glycaemic control
in diabetes-related studies; however, both the disease and the
change effort may cause or alleviate a burden to the patient or
to the provider. Therefore, it may be appropriate to measure
behavioural or functional factors such as quality of life or
satisfaction. Cost is often an important variable in change
efforts. It is imperative that the investigator look at the process
and the proposed improvement plan and determine a reason-
able, balanced approach (sometimes referred to as a ‘‘data
dashboard’’) to measure those factors that are likely to be
affected by the improvement intervention. Consensus panel
guidelines and quality indicators are helpful in guiding the
investigator’s choice of measures, but the local environment and
problem should be considered to optimise the measures chosen.
Once the measures have been chosen, the investigator needs
to develop operational data definitions, collection forms and
determine how the data will be collected. The methods of data
collection and data quality management should be described in
the paper so that others may replicate the project. In the
example above, chart abstraction was used to collect the data.
The authors explain in detail how the data were abstracted and
how a random sample was chosen for dual abstraction to
confirm the adequacy of the abstraction method and the data.
The manuscript should also ensure that the factors being
study are reliably measured. For biological specimens, this may
include describing the laboratory process used or the method of
specimen collection and handling. Behavioural domains should
be measured with validated instruments. If a new scale is
created for the change effort, then the reliability and validity of
the scale should be described. The validity should include a
construct validity model or comparison to a gold standard, if
available. This informs the reviewer and reader that the measure
accurately represents the factor or domain that was being
assessed.
12 Analysis
a. Provides details of qualitative and quantitative (statistical)
methods used to draw inferences from the data
b. Aligns unit of analysis with level at which the intervention
was applied (if applicable)
c. Specifies degree of variability expected in implementation,
change expected in primary outcome (effect size) and
ability of study design (including size) to detect such effects
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time as a variable (for example, statistical process control).
Examples
(a) ‘‘By monitoring the number of days between infections, the g
chart has greater detection power for rare events compared with
conventional binomial based approaches. Whenever a CR-BSI
[catheter related bloodstream infection] occurred we added the
data point to our g chart and calculated the number of days from
the previous infection. …The g chart is a type of statistical
process control (SPC) chart and therefore requires a basic
understanding of the principles inherent to SPC. … At the start
of the project we constructed a baseline (preintervention) g chart
by querying the NNIS [National Nosocomial Infection
Surveillance System] database from 1 January 2000 to 31 October
2002 (fig 1, observations 1–39). We only plotted CR-BSIs on the g
chart for catheters inserted by the MICU - for example, dialysis
catheter CR-BSIs were not included on the g chart.
‘‘We measured the average time between infections (27 days) and
used Benneyan’s method for calculating an upper control limit
(UCL=109 days) at three standard deviations above the pre-
intervention mean. During the pre-intervention period the
number of days between infections was consistently below the
UCL. The absence of any points above the UCL suggested that
the variation in time between CR-BSIs was inherent to our
current process of care (that is, common cause), and that the
proper way to reduce the CR-BSI rate was through process
redesign or CQI. Our goal was to reduce the CR-BSI rate and
thereby increase the time between events. Based on the g-chart,
we considered our intervention successful if data points fell above
the UCL since this would correspond to a decreased CR-BSI
rate.’’
23
(b) ‘‘All audiotaped interviews were transcribed verbatim. Two
researchers...independently reviewed the manuscripts and
marked comments about barriers to adherence. Remarks of
professionals were compared and classified into categories of
potential barriers to physician adherence according to a
conceptual model…. The two reviewers discussed all the remarks
that they had individually highlighted and classified until
consensus was reached. They consulted a third researcher to
make a formal judgment about differences in classification. If
controversy remained, the comment was considered ambiguous
and was excluded.’’
34
Explanation
The analysis plan is intimately related to the study design. A
defining characteristic of quality improvement is to show that
the strategy for change (which is often multi-faceted) works to
bring about a measurable difference in the process or outcome
measures. Such demonstrations have resulted in a plethora of
before-after studies comparing two data points, one value
representing the pre-intervention period and the second value
representing the post-intervention period. Such two-point
before-after analyses are weak demonstrations of change;
consequentially, they are generally considered pre-experimental,
and hence acceptable as secondary, hypothesis-generating
contributions, which require additional hypothesis-testing
analysis.
Strong demonstrations of improvement projects overcome
the limitation of before-after analysis by capitalising on the
concept of replication. The strength of replication is that it
accumulates confidence that the intervention produces the
pattern of change observed in the results. Example (a) from Wall
et al uses replication in the form of statistical process control
(SPC) analysis to demonstrate a change from pre-intervention
(baseline phase) to post-intervention (implementation phase).
The authors state the type of SPC that was used (‘‘g-chart’’),
the timeframe for the baseline data (‘‘1 January 2000 to 31
October 2002’’) and the inclusion criteria for the data (‘‘for
catheters inserted by the MICU’’), thus specifying the analysis
for the main outcome measure in the study. SPC is within the
family of time-series analyses that plot multiple points, and
where each point represents the operationally defined unit of
measurement (such as a daily, weekly or monthly proportion,
mean or time between events). We recommend consultation
with a statistician familiar with time series analysis at the start
of a study to ensure that the analysis is appropriate for the
questions that are posed.
SPC requires a stable baseline from which to evaluate changes
(improvements) that occur, but healthcare systems are also
subject to secular trends that may appear in any given period of
pre-intervention and during the intervention period. For these
instances, other analytical techniques may be more appropriate.
For example, the interrupted time series technique estimates the
intervention’s effects and tests for statistical significance of
Figure 1 Example of a statistical process control chart (g-chart) with notation of when intervention occurred. UCL, upper control limit.
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Alternatively, some authors may choose to use sophisticated
statistical techniques that have been employed in longitudinal
or time-dependent studies.
31 These are appropriate for use in
analysis of quality improvement, but these more sophisticated
statistical techniques usually require consultation with a
statistician for appropriate design, analysis and interpretation.
Also note that replication is a two-edged sword in the
evaluation of complex social interventions. Particular interven-
tions work well in some contexts but poorly, or not at all, in
others. In the aggregate, therefore, introducing a complex social
intervention into many different contexts is likely to lead to a
null result overall, even when the intervention is effective in at
least some settings.
Finally, not all quality improvement research is quantitative.
Example (b) by Schouten et al demonstrates a brief description
of qualitative analytic methods.
34 Qualitative research is rich in
discovering knowledge of root causes, understanding flow of
process, formulating concept classifications and themes and
gaining insight into mechanisms of change, context, perspective
and perception. While simply relating anecdotes from qualita-
tive studies can be powerful in affecting memory, attitudes and
beliefs, qualitative research involves the use of systematic,
rigorous and robust study techniques. Schouten’s example
clearly describes how the interview data were transcribed,
extracted, summarised and adjudicated. Other qualitative
methods might use ethnographic or qualitative analysis soft-
ware, provide evidence of inter-rater reliability or provide
procedural detail for replicable data classification schemes.
Authors who use qualitative study designs should also consult
the guidelines for reporting of observational studies (STROBE)
4
to be sure the methods and descriptions are consistent with
those recommendations.
13 Outcomes
(a) Nature of setting and improvement intervention
a. Characterises relevant elements of setting or settings (for
example, geography, physical resources, organisational
culture, history of change efforts), and structures and
patterns of care (for example, staffing, leadership) that
provided context for the intervention
b. Explains the actual course of the intervention (for example,
sequence of steps, events or phases; type and number of
participants at key points) preferably using a time-line
diagram or flow chart
c. Documents degree of success in implementing intervention
components
d. Describes how and why the initial plan evolved, and the
most important lessons learned from that evolution,
particularly the effects of internal feedback from tests of
change (reflexiveness).
Example
‘‘The project began with the creation of four working groups that
met regularly to work on specific component parts of the
pathway. The results from each working group are summarized
on Table 2 and discussed in detail below.’’
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Explanation
The results section should include a detailed explanation of the
characteristics of the intervention, such as intensity and
integrity, changes in the intervention over time, cost, attrition
rates and sustainability. Because quality improvement studies
evolve in ‘‘real-world’’ settings, and improvement involves
context-sensitive change mechanisms, reporting the local
context is essential (see item 4, Local problem, and item 8,
Setting). If not included in the Local problem or Setting section,
authors should include specific details about the clinic setting,
patient population, previous experience with system change
and how the context contributed to understanding the problem
for which the study was designed. This article discussed these
specifics in the Setting section (see item 8 above). Ideally, this
section should also discuss the nature of the facility’s previous
experience with, and commitment to, meaningful change.
It is likely that an intended improvement strategy will evolve
over time in response to feedback from the environment and in
response to changes in that environment over time.
Improvement leaders and researchers should anticipate this
evolution. When reporting on the results, this evolution should
be captured. Often this is best done with a timeline or table that
demonstrates changes over time, as in this example. The table
from this example shows that the intended initial change
strategy involved independent working groups that met in
isolation. As the project progressed, however, it became clear that
the work needed to be integrated. The table shows this evolution
by indicating that by thespringof 2003, allof the working groups
were participating in the same process of mock drills.
The success or failure of an individual improvement plan will
be related to the inherent nature of the improvement as well as
the interaction of that improvement within a particular setting.
This example demonstrates the change in the improvement over
time and how that affected the individuals in the organisation.
Readers are then able to determine how their own organisation
is similar to and different from the one whose change is
described.
13 Outcomes
(b) Changes in processes of care and patient outcomes associated
with the intervention
a. Presents data on changes observed in the care delivery
process
b. Presents data on changes observed in measures of patient
outcome (for example, morbidity, mortality, function,
patient/staff satisfaction, service utilisation, cost, care
disparities)
c. Presents evidence regarding the strength of association
between observed changes/improvements and intervention
components/context factors
d. Includes summary of missing data for intervention and
outcomes.
Example
‘‘Study Flow
…. Of the 205 providers, 23 were subsequently excluded after
randomization because patients did not consent (n=222) or
because chart review showed that a patient was taking more
than 1 medication (n=264). …At trial completion, 975 patients
(73%) had at least 1 follow-up blood pressure reading, including
255 of 324 (78.7%) in the provider education only group, 362 of
547 (66.2%) in the provider education and alert group, and 358 of
470 (76.2%) in the provider education, alert, and patient
education group.
Outcome Measures: Systolic and Diastolic Blood Pressure
…the proportion achieving goal blood pressure {SBP (140 mm
Hg} differed in the 3 groups: 107 of 255 (42.0%) versus 148 of 362
(40.9%) versus 213 of 358 (59.5%) (P=0.003) in the provider
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alert, and patient education groups, respectively. … There were
no between-group differences in this secondary outcome
{DBP,90 mm Hg} (P=0.81) …
Process Measures: Intensification of Antihypertensive Regimen
and Adherence
…[I]ntensification of antihypertensive medications was done in
32.4% of patients in the provider education only group, 28.5% in
the provider education and alert group, and 29.1% in the provider
education, alert, and patient education group (P=0.81) …
Medication adherence (pharmacy refills) was also measured after
intervention, and there were no differences in medication
adherence score among study groups … (P=0.71).
… Death during Follow-up
During the study period…1.1% participants died (8 [2.5%] in the
provider education only group, 3 [0.6%] in the provider education
and alert group, and 4 [0.9%] in the provider education, alert, and
patient education group; P=0.027).’’
17
Explanation
In addition to providing specific details of the setting,
intervention(s), and project evolution, it is equally important
to describe changes in patient care and outcomes that occurred
in response to the project. Data related to specific process and
outcomes measures can be reported as shown in the above
example. The study flow diagram (fig 2) combined with the text
provides a clear picture of the study design at a glance and lay
out the flow of participants over time.
37 Providing this level of
detail—in combination with a description of the evolution of
the changes—helps readers to determine generalisability, or
external validity, of the study.
Criteria to determine external validity for implementation
studies have been suggested by Glasgow et al and include the
following
38: (1) representativeness of the sample (target
audience, inclusion and exclusion criteria, participation, set-
tings, individuals); (2) programme or policy implementation
and adaptation (consistency, staff expertise, programme custo-
misation); (3) outcomes for decision-making (significance,
adverse consequences, programme intensity, costs, moderator
effects—such as subgroups of participants/settings); and (4)
maintenance and institutionalisation (long-term effects, sus-
tainability, evolution, attrition). Each is demonstrated in the
example. In the ‘‘Study flow’’ section of this example, the
dropout rate and the magnitude of missing data over time are
clearly stated. A situational analysis—which was not included
in this examples—often includes the actual usage of the
intervention, the degree of success in implementing the
intervention and how and why the initial plan for improvement
evolved (linked to the initial context description in item 4, Local
problem, item 5, Intended improvement and item 8, Setting).
Such analysis is sometimes considered beyond the scope of the
main findings, but can be extremely important in under-
standing why an improvement intervention did or did not work
in a particular setting. Finally, planned interventions that are
not fully implemented as intended may result in less reliable
findings, so these should also be reported in the manuscript.
Depending upon the study design, results may include means,
proportions, standard deviations, risk ratios, confidence inter-
vals or time-series. Furthermore, unexpected findings (harms or
benefits), organisational impact, and difficulties implementing
the intervention should be reported as well as the magnitude
(effect size) and strength of associations. In the example, the
indicated magnitude and strength of association with patient
outcomes (Outcome measures: Systolic and diastolic blood
pressure), processes of care (Process measures: Intensification of
Table 2 Example of a display of the changes that occurred over time
Summary of working group improvement efforts by phase of implementation
Phase Date complete
Interventions by working groups
Birthing centre nurses Providers Anaesthesia Operating room
1 Summer 2002 c Analysed tasks c Established dedicated CD
phone line
c Created OB anaesthesia
questionnaire
c Purchased dedicated OR infant
‘‘stabilet’’
c Reassigned inappropriate
tasks
c Programmed on-call team
members into computer
c Placed completed
questionnaire on birthing
centre
c Prepare OR for ‘‘STAT’’ CD each
evening
c Eliminated unnecessary tasks
(eg, transfer of patient to
stretcher)
c Programmed birthing centre
phones with CD line on
speed dial
c Developed process for
antenatal anaesthesia
consults
c Trained birthing centre nurses
to check ‘‘stabilet’’ and OR
preparedness each evening
c Organised supplies into CD
kits
c Instituted mightly test of
system with mandatory call
back requirement
c Review OB high risk and
VBAC lists each week
2 Spring 2003 c Replaced OR checklist with
CD specific checklist
c Designated codes to
indicate ‘‘STAT’’ v routine
CD
c Recommend CBC, type and
screen on all labouring
women
c Used mock CDs to identify
steps in routine process that
could be eliminated during
emergency
c Developed standardised
terminology
c Worked with providers to
develop standardised
terminology
c Synchronised OR clocks with
birthing centre clocks
c Distributed flow charts of
‘‘STAT’’ process
c Created standardised brief
operative note
c Assisted with development
of ‘‘STAT’’ process map
c Assisted with development of
‘‘STAT’’ process map
c Finalised ‘‘STAT’’ process
map
c Assisted with development
of ‘‘STAT’’ process map
3 Spring 2004 c Participated in OR skills day
and ‘‘STAT’’ pathway mock
drills
c Participated in OR ‘‘skills
day’’ and ‘‘STAT’’ pathway
mock drills
c Participated in OR ‘‘skills
day’’ and ‘‘STAT’’ pathway
mock drills
c Participated in OR ‘‘skills day’’
and ‘‘STAT’’ pathway mock
drills
c Empowered nurses and CNMs
to transport patients to OR in
emergency
c Trained nurses in anaesthesia
set up
c Trained nurses in OR set up
CD, caesarean delivery; OR, operating room; VBAC, vaginal birth after previous caesarean section.
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14 SUMMARY
a. Summarises the most important successes and difficulties in
implementing intervention components, and main changes
observed in care delivery and clinical outcomes
b. Highlights the study’s particular strengths.
Example
‘‘The new PSMMC [patient safety morbidity and mortality
conference] provides a constructive venue for residents, fellows
and faculty to express concerns about the healthcare system.
Although altering the popular traditional MMC [morbidity and
mortality conference] had inherent risk, the successfully executed
transition has enhanced the overall experience for staff and
faculty. The conference has remained a popular educational
forum, with increased participation as measured by attendance.
The growth in attendance noted seems to represent both higher
levels of interest among medical residents as well as increased
frequency of attendance by other healthcare professionals who
are invited to participate in interprofessional care discussions.
The response of the medicine residents and fellows has shown
that they are capable and often enthusiastic about generating
ideas for needed changes in systems of care. The attitudes of
residents and fellows improved in key areas following the change,
including the belief that positive departmental changes were
likely to result from the analyses of medical errors and
subsequent improvement actions.’’
39
Explanation
In this example, the main improvements and outcomes are
clearly summarised. The tension between the value of a brief
summary of key findings versus a thorough restatement of all
the findings in the study is demonstrated. The conscientious
reader will digest the entire results and discussion sections for a
more nuanced understanding of the outcome. This example was
taken from a report of a single-institution study that employed
multiple cycles of changes to an educational conference, and
this summary flows logically from item 6, Study question, item
8, Setting, item 9, Planning the intervention, item 10, Planning
the study of the intervention and item 13, Outcomes. The
results section has tables and text to describe the details of the
clinical and educational outcomes of this project. This level of
detail is correctly placed in those sections and does not need to
be repeated in the summary. The summary above focuses on the
important strengths and outcomes (growth in attendance,
attendance by non-physician healthcare professionals and
Figure 2 Study flow diagram.
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out.
15 Relation to other evidence
c Compares and contrasts study results with relevant findings
of others, drawing on broad review of the literature; use of a
summary table may be helpful in building on existing
evidence.
Example
The self-management of asthma is recognised as an effective
strategy in reducing morbidity. In the past, education pro-
grammes in the self-management of asthma have focused on
primary schoolchildren or adults. Initiatives for asthma educa-
tion for young people, aimed at individuals with asthma, have
had minimal impact on asthma morbidity, and education
programmes conducted in hospitals have problems attracting
young people. In our study, the students who were educated by
their peers had a lower number of reported asthma attacks and
school absenteeism compared with the control group.
Improvements in quality of life and asthma morbidity failed
to cascade from year 10 into year 7 because the year 7 students
only received the performances about asthma and not the peer-
led teaching.
Interventions using peer education may have a higher chance
of success in adolescence than other types of interventions. In a
meta-analysis of 143 programmes in drug prevention in
adolescents, the effect size was largest for peer teaching
programmes than for other teaching strategies. Young people
seem to prefer peers for advice, and change is more likely to
occur if someone they can relate to or perceive as a role model
relays the message. Additionally, peer educators enhance the
programme’s effect by directing peer pressure in a positive
direction.
40
Explanation
Readers will want to know how the reported results relate to
those of other published studies, both in terms of the results and
impact of the intervention and in terms of the format and
delivery of the intervention. Findings from individual studies are
greatly enhanced when compared and contrasted with pre-
viously published articles. Authors should always compare their
study results with appropriate findings from other relevant
published work. This discussion should be as systematic as
possible and not be limited to studies that support the results of
the current study and, if available, there should be reference to
existing systematic reviews. Use of tables and figures to help
compare and summarise previous work may also be helpful.
Such information should help readers assess whether the
results of the study are similar to those of other relevant studies,
and whether the particular intervention that was used explains
any noted differences. Reference may well be both to studies of
the subject of the quality improvement research (such as
asthma management in the above example) and to published
literature on quality improvement interventions (for example,
audit, academic detailing, change management strategies). The
example provides a concise and reasonable assessment of recent
literature by relating findings from the present study to those
from other studies that are likely to be summarised in the cited
meta-analysis. These comparisons provide the reader with a
solid foundation upon which to anchor the findings of the
current report. Finally, authors should explain how the new
study adds to the existing body of evidence. This is not done in
the example above, but is an important consideration.
16 Limitations
a. Considers possible sources of confounding, bias, or impreci-
sion in design, measurement and analysis that might have
affected study outcomes (internal validity)
b. Explores factors that could affect generalisability (external
validity)—for example, representativeness of participants;
effectiveness of implementation; dose-response effects;
features of local care setting
c. Addresses likelihood that observed gains may weaken over
time, and describes plans, if any, for monitoring and
maintaining improvement; explicitly states if such planning
was not done
d. Reviews efforts made to minimise and adjust for study
limitations
e. Assesses the effect of study limitations on interpretation
and application of results.
Example
This study included multiple healthcare organisations and
community agencies in a single metropolitan area rather than
a single healthcare organisation and multiple community
agencies from several regions. This approach minimised
concerns of healthcare organisations in a single region about
possible adverse selection of patients with dementia after the
creation of enhanced services, and it more realistically reflected
patterns of use of community resources encouraged by the
chronic care model.
We adjusted for healthcare organisation provider but not for
care manager because two healthcare organisations employed
only one care manager each, thereby precluding our ability to
distinguish healthcare organisation from care manager effects.
We decided a priori to adjust for healthcare organisation rather
than for care manager. The care managers received identical
training and used the same assessments and treatment
protocols, whereas we purposively recruited healthcare organi-
sations with diverse characteristics and believed that healthcare
organisation rather than care manager differences would
influence outcomes. Dyads in the intervention group could be
referred to multiple community agencies, depending on the
service needs identified through the assessment of healthcare
organisation care manager; referral to a community agency was
a study outcome. Thus, we did not adjust for community
agency care manager.
Our study sample was well educated, was predominantly
white, had relatively few co-morbid conditions and was not
institutionalised. Accordingly, the intervention may need to be
modified for institutionalised patients and for those without a
usual source of care and stable insurance. Secondary outcomes
and some care process measures were self-reported, but multi-
item scales met standards for reliability, and support for validity
has been reported for several measures. As with almost any
quality improvement intervention study, medical record
abstractors could have discerned aspects of the study interven-
tion, and we did not assess the extent to which abstractors were
blinded to intervention status. It is possible that medical record
documentation may incompletely reflect actual care processes,
but we believe that observed differences reflect actual differ-
ences in care rather than differences in documentation because
this care management intervention was based on a model in
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Explanation
The authors of this report identified a number of factors that
could have introduced bias and affect the study measures. These
included self-reporting of outcome and process measures, lack of
blinding of medical record abstractors to the study interventions
and the decision to adjust for healthcare providers but not for
the community agency care managers. A description of efforts
to control for these factors and minimise their effects either in
the study design or the analysis of results should be included in
the limitations section. In addition, insight into how the
identified factors could have potentially affected the study
measures, by either artefactually increasing or decreasing the
effects of the described intervention, should be included in the
limitations section.
This section should also explore why the particular study
design was chosen and whether it reflects clinical practice in a
realistic fashion. The authors in this example note that they
chose their design with multiple healthcare agencies in a single
area to reduce adverse selection of patients and to better reflect
practice based on the chronic care model. Although this study
design may be helpful for those who are planning care for
multiple practices, this study design may not be as helpful for
the individual practitioner who may be interested in imple-
menting the described interventions into a single practice
location.
This particular study was a randomised, controlled trial, a
study design that typically makes use of multiple inclusion and
exclusion criteria to ensure that the intervention and control
groups are similar. Although this may improve the internal
validity of the study by reducing the effects of confounding or
selection bias from different study populations (or in this
example, different clinical practices), it may also reduce the
external validity or generalisability of the study as the included
patient populations or practices may not resemble the diverse
practices, providers or patients that exist in actual clinical care.
Finally, the limitations section should identify particular
factors in the context and patient population that may affect
generalisability. The success of improvement interventions
depends on the specific contexts in which they occur; therefore,
identification of unique traits or characteristics of the patient
population, providers, institution or geographical setting is
critical. A clear understanding of the local setting in which the
intervention is implemented is important to the reader who is
interested in applying the described interventions in their own
particular setting and population of patients. The authors
identified their patient population as unlikely to be representa-
tive of other populations across the country, suggesting that the
study’s providers and practice settings are likely to be different
from many other practices that care for patients who have
dementia. The impact of this discrepancy could be mitigated by
the inclusion of more information about particular aspects of
the providers and practice settings that could affect the study
outcomes.
17 Interpretation
a. Explores possible reasons for differences between observed
and expected outcomes
b. Draws inferences consistent with the strength of the data
about causal mechanisms and size of observed changes,
paying particular attention to components of the
intervention and context factors that helped determine
the intervention’s effectiveness (or lack thereof) and types
of settings in which this intervention is most likely to be
effective
c. Suggests steps that might be modified to improve future
performance
d. Reviews issues of opportunity cost and actual financial cost
of the intervention.
Example
‘‘…There are at least 2 plausible explanations or the significant
reductions in hospital-wide mortality and code rate outside of the
pediatric ICU [Intensive Care Unit] setting witnessed at our
hospital vs. other pediatric hospitals. First, LPCH [Lucile Packard
Children’s Hospital] serves a particularly high risk population of
hospitalized children. …As a result, we speculate that LPCH has
a higher proportion of children at risk for codes on its medical
and surgical wards than do children’s hospitals with lower case
mix indexes. …This difference in case mix index likely explains
why this study found significant improvements in code rate and
mortality rate only when including patients who met RRT [rapid
response team] criteria, and why the study by Brilli et al found a
significant decrease in code rate per 1000 patient-days only when
using a single tailed statistical test. …A second possible
explanation for our improved outcomes is that our postinter-
vention period is substantially longer than both Melbourne’s
(12 months) and Cincinnati’s (8 months).
‘‘[T]hese improved outcomes have continued despite turnover
among the resident physicians, nurses, and other staff, suggesting
that the team rather than the education associated with the
rollout is more likely the source of the improvements…. This
explanation is supported by the decrease in RRT calls during the
19-month intervention period to levels below the effective
threshold suggested by the Institute for Healthcare Improvement
(20–25 calls per 1000 discharges).
‘‘…Strategies other than an RRT that identify and respond to
patients earlier in the course of a decompensation could have the
same effect as an RRT. For example, 1 potential strategy to
decrease codes outside of the ICU [intensive care unit] setting
suggested by Winters et al is the integration of hospitalists. We
are in a good position to evaluate a hospitalist intervention at a
local level, because we introduced a medical-surgical ward
hospitalist service 26 months (July 2003) before RRT imple-
mentation. Assuming that there was no delayed effect, the
introduction of the hospitalist service, although valuable for
multiple reasons, did not affect either mortality rate or code rate
outside of the ICU setting….
‘‘… Future research should focus on replicating these findings in
other pediatric inpatient settings, including settings where
children are treated in predominantly adult-focused hospitals,
developing efficient methods for implementing RRTs, and
evaluating the cost effectiveness of this intervention.
‘‘…At LPCH, the RRT program was designed and implemented
with no additional increase in funding for staffing, a decision
supported by the time allocation required for calls during the first
19 months of the intervention.’’
42
Explanation
An improvement project is typically focused on identifying an
association between an intervention(s) and some outcomes.
The nature and degree of the change in outcome may arise from
theory, research, or previous improvement studies and is usually
stated in the Introduction section of the paper (item 5, Intended
improvement and/or item 6, Study question). If the actual
outcome deviates from the expected outcome or if the outcome
is different from that observed in other published studies (as in
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discussion of the factors that prevented the expected outcome
from occurring. In quality improvement studies, the explana-
tion should include the situation factors (context) that may
have led to these differences.
The interpretation section elaborates on the information
reported earlier in the results section by describing the practical
implications of findings. A statistical difference in outcomes is
not sufficient as an explanation, so the internal and external
implications of the findings should be explored. Competing
theories and other causes of the outcomes should be investi-
gated, such as the discussion regarding hospitalists in the
example. Sources of bias and confounding are often addressed in
the Limitations (item 16) section, but may be introduced here
also. The intricacies about the various interventions and the
contextual factors that may interact with the interventions in
other settings could also be noted.
The interpretation often includes ‘‘lessons learned,’’ observa-
tions, and suggestions for improving the implementation of the
interventions in other organisations. This may include the
following:
c Background or cultural elements that should be in place
before attempting implementation of the intervention
c Suggested sequence of steps for implementation
c Possible adaptations of the interventions
c Additional studies that could reinforce or enhance the
findings.
The example includes a description of the possible future
exploration regarding rapid response teams. This helps the
reader identify where these current findings may and may not
be applicable, thus enhancing the ability to interpret the
context of the results.
Finally, it is often helpful to include some information that is
relevant to the business case for the intervention that could help
readers with the decision whether to adopt the change. One
way to do this is to describe the resource and cost information
associated with the reported study as in the above example. The
authors also may describe the financial implications of the
change in outcomes observed in the study. Authors should be
aware of the intricacies and details that are required for an in
depth economic analysis. The ISPOR RCT-CEA guidelines for
cost-effectiveness studies that are alongside clinical trials may be
helpful.
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18 Conclusions
a. Considers overall practical usefulness of the intervention
b. Suggests implications of this report for further studies of
improvement interventions.
Example
‘‘After demonstrating the feasibility of DMP [Discharge
Medication Program] implementation throughout the 10 pilot
institutions and its success in producing high adherence to
discharge medication guidelines, IHC [Intermountain Health
Care] expanded the program to include all 21 hospitals in the
system. The DMP is now a solidly integrated program that
continues to produce high rates of adherence to cardiovascular
medication guidelines.
…Implementation of the DMP within the 10 hospitals required
no additional employees. Adherence was tracked by using the
existing hospital medical informatics infrastructure, adding only
minimal cost to hospital operations. Consequently, we believe
that cost was low relative to the numbers of lives potentially
saved, especially when compared with recent improvements in
cardiovascular care, such as drug-eluting coronary stents.
The comprehensiveness of the DMP is also substantially limited
because patients were enrolled only if their principal diagnosis
was cardiovascular. For instance, if a cardiovascular patient was
admitted to the hospital with some other diagnosis, such as hip
fracture, the DMP in our study would not have affected his or her
discharge medications. Thus, this DMP could be used to treat
even more patients if it were expanded to include everyone
admitted with secondary diagnoses of cardiovascular disease.
Our study demonstrates that a relatively simple quality
improvement project aimed at enhancing the use of appropriate
discharge medications in patients hospitalized with a cardiovas-
cular diagnosis is feasible and can be sustained on a large scale in
a multihospital integrated system. Most important, our findings
suggest that such a program may have substantial long-term
lifesaving benefits across a broad system of integrated hospi-
tals.’’
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Explanation
The conclusion to a quality improvement paper should
summarise the lessons learned from the project and detail the
potential next steps for investigation. It should also describe
how the successes of the project (if applicable) will be
maintained or expanded. In the above example, the authors
include the information that their improvement programme has
been expanded to the other institutions in their hospital system
and that improvement is being monitored through rates of
adherence to cardiovascular medicine guidelines. This is one
example of generalisability within the same organisation.
Conclusions may also describe how the local context might
translate to other clinical arenas. Reflections as to what might
be necessary to sustain the improvement or to test the
improvement intervention in another care setting are helpful.
Finally, suggestions as to possible next steps are also useful. The
authors in this example suggest other patient populations who
may benefit from the intervention. The goal of the conclusion is
not only to summarise the local implications of the project, but
also to provide insights to those readers who are considering the
applicability of the presented intervention to their local care
setting. Finally, it is useful for authors to consider, ‘‘What
important questions does this study leave unanswered?’’ and
‘‘What studies would be most useful to answer those questions?
Why?’’
19 Funding
c Describes funding sources, if any, and role of funding
organisation in design, implementation, interpretation, and
publication of study.
Example
‘‘Role of the Funding Source
This study was sponsored by the U.S. Department of Veterans
Affairs (Veterans Integrated Service Network [VISN]
Implementation grant), Clinical Research Center of Excellence,
and Center for Patient Healthcare Behavior. The principal
investigators and coinvestigators had full access to the data and
were responsible for the study protocol, statistical analysis plan,
study progress, analysis, study reporting, and the decision to
publish the paper. The U.S. Department of Veterans Affairs–
VISN 9 had the opportunity to comment on the manuscript
before submission.’’
17
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Funding for improvement may arise from many sources: local
institutional, a group of organisations that join together, a
governmental granting agency, a foundation granting organisa-
tion or even from a third party payment. The description of the
funding source can be brief, as in the example above, but should
be thorough enough for the reader to understand which parties
had a financial stake in the project. This example also clearly
describes that the regional VA leadership in VISN 9 had an
opportunity to comment on the paper. Transparency regarding
the source of the funding as well as the level of input from the
funding agency assists with the interpretation of the outcomes.
This level of unambiguous clarity is particularly important in
light of recent data that cast doubt on the role of authors in
some studies funded from industry.
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COMMENT
Guidelines form an important bridge between the completion of
a project and the sharing of the conclusions with others. As
CONSORT
12and STARD
3 have provided guidance for report-
ing randomised controlled trials and tests of diagnostic
accuracy, the SQUIRE guidelines provide structure for the
reporting of improvement work. Because the guidelines
themselves are brief by design, this E & E document provides
additional specificity regarding details of that structure.
As you read and use these guidelines and the E & E document,
you may have questions or comments about individual items in
the guidelines, about examples that were chosen, about the
guidelines or the E & E document as a whole. We intend this
E & E as a starting point for ongoing dialogue about the
implementation and evaluation of the SQUIRE guidelines.
Please visit our website at www.squire-statement.org. The
website has full and short versions of the guidelines, a glossary
of terms used in the guidelines and this E & E document. The
website is designed to facilitate a moderated, threaded discus-
sion about individual guidelines and the guidelines as a whole. If
you are submitting a manuscript to a journal that does not
explicitly endorse the SQUIRE guidelines, we encourage you to
refer the editor(s) and reviewers to the website so that they may
become familiar with these guidelines.
The planning, implementation, analysis and reporting of
improvement work continue to evolve. This E & E document
provides a snapshot of existing examples that help to illustrate
the many important and nuanced issues in doing, studying, and
reporting QI work. Ideally, these examples will be supplanted
by hundreds of additional ones in the coming months and years,
as the SQUIRE guidelines are used widely throughout the
improvement community.
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